Corvus Pharma Announces Executive and Board Changes
Ticker: CRVS · Form: 8-K · Filed: Apr 9, 2025 · CIK: 1626971
| Field | Detail |
|---|---|
| Company | Corvus Pharmaceuticals, Inc. (CRVS) |
| Form Type | 8-K |
| Filed Date | Apr 9, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, board-of-directors, executive-appointment
TL;DR
Corvus Pharma shakes up leadership with new CMO and board members.
AI Summary
Corvus Pharmaceuticals, Inc. announced on April 8, 2025, changes in its executive and director roles. The company appointed Dr. Richard A. Miller as Chief Medical Officer and elected Ms. Jennifer L. D. Allison and Mr. David M. E. Smith to its Board of Directors. These appointments are effective immediately.
Why It Matters
These leadership changes could signal a strategic shift or a focus on specific areas of growth and development within the company.
Risk Assessment
Risk Level: medium — Changes in key executive and board positions can introduce uncertainty regarding future strategy and execution.
Key Players & Entities
- Corvus Pharmaceuticals, Inc. (company) — Registrant
- Dr. Richard A. Miller (person) — Appointed Chief Medical Officer
- Ms. Jennifer L. D. Allison (person) — Elected to Board of Directors
- Mr. David M. E. Smith (person) — Elected to Board of Directors
- April 8, 2025 (date) — Date of earliest event reported
FAQ
Who has been appointed as the new Chief Medical Officer?
Dr. Richard A. Miller has been appointed as the new Chief Medical Officer.
Who were elected to the Board of Directors?
Ms. Jennifer L. D. Allison and Mr. David M. E. Smith were elected to the Board of Directors.
What is the exact date of the earliest event reported in this filing?
The date of the earliest event reported is April 8, 2025.
What is the principal executive office address of Corvus Pharmaceuticals, Inc.?
The address of the principal executive offices is 901 Gateway Boulevard, Third Floor, South San Francisco, CA 94080.
What is the Commission File Number for Corvus Pharmaceuticals, Inc.?
The Commission File Number for Corvus Pharmaceuticals, Inc. is 001-37719.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 9, 2025 by Dr. Richard A. Miller regarding Corvus Pharmaceuticals, Inc. (CRVS).